These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 27187163)

  • 21. MRI-directed biopsy for primary detection of prostate cancer in a population of 223 men: MRI In-Bore vs MRI-transrectal ultrasound fusion-targeted techniques.
    Del Monte M; Cipollari S; Del Giudice F; Pecoraro M; Bicchetti M; Messina E; Dehghanpour A; Ciardi A; Sciarra A; Catalano C; Panebianco V
    Br J Radiol; 2022 Mar; 95(1131):20210528. PubMed ID: 34609900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimal sampling scheme in men with abnormal multiparametric MRI undergoing MRI-TRUS fusion prostate biopsy.
    Freifeld Y; Xi Y; Passoni N; Woldu S; Hornberger B; Goldberg K; Bagrodia A; Raj G; Margulis V; Cadeddu JA; Lotan Y; Francis F; Pedrosa I; G Roehrborn C; Costa DN
    Urol Oncol; 2019 Jan; 37(1):57-62. PubMed ID: 30446460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients.
    Baco E; Ukimura O; Rud E; Vlatkovic L; Svindland A; Aron M; Palmer S; Matsugasumi T; Marien A; Bernhard JC; Rewcastle JC; Eggesbø HB; Gill IS
    Eur Urol; 2015 Apr; 67(4):787-94. PubMed ID: 25240973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Real-time MRI/US fusion-guided biopsy in biopsy-naïve and pre-biopsied patients with suspicion for prostate cancer].
    Maxeiner A; Stephan C; Fischer T; Durmus T; Kilic E; Asbach P; Haas M; Günzel K; Neymeyer J; Miller K; Cash H
    Aktuelle Urol; 2015 Jan; 46(1):34-8. PubMed ID: 25519051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of patient comfort between MR-guided in-bore and MRI/ultrasound fusion-guided prostate biopsies within a prospective randomized trial.
    Arsov C; Rabenalt R; Quentin M; Hiester A; Blondin D; Albers P; Antoch G; Schimmöller L
    World J Urol; 2016 Feb; 34(2):215-20. PubMed ID: 26055645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Follow-up of negative MRI-targeted prostate biopsies: when are we missing cancer?
    Gold SA; Hale GR; Bloom JB; Smith CP; Rayn KN; Valera V; Wood BJ; Choyke PL; Turkbey B; Pinto PA
    World J Urol; 2019 Feb; 37(2):235-241. PubMed ID: 29785491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic resonance imaging-targeted, 3D transrectal ultrasound-guided fusion biopsy for prostate cancer: Quantifying the impact of needle delivery error on diagnosis.
    Martin PR; Cool DW; Romagnoli C; Fenster A; Ward AD
    Med Phys; 2014 Jul; 41(7):073504. PubMed ID: 24989418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Manually controlled targeted prostate biopsy with real-time fusion imaging of multiparametric magnetic resonance imaging and transrectal ultrasound: an early experience.
    Shoji S; Hiraiwa S; Endo J; Hashida K; Tomonaga T; Nakano M; Sugiyama T; Tajiri T; Terachi T; Uchida T
    Int J Urol; 2015 Feb; 22(2):173-8. PubMed ID: 25316213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective evaluation of magnetic resonance imaging guided in-bore prostate biopsy versus systematic transrectal ultrasound guided prostate biopsy in biopsy naïve men with elevated prostate specific antigen.
    Quentin M; Blondin D; Arsov C; Schimmöller L; Hiester A; Godehardt E; Albers P; Antoch G; Rabenalt R
    J Urol; 2014 Nov; 192(5):1374-9. PubMed ID: 24866597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsy Ready for "Prime Time"?
    Loeb S
    Eur Urol; 2015 Jul; 68(1):20-1. PubMed ID: 25465339
    [No Abstract]   [Full Text] [Related]  

  • 31. Multiparametric magnetic resonance imaging/transrectal ultrasound fusion targeted biopsy of the prostate: preliminary results of a prospective single-centre study.
    Junker D; Schäfer G; Heidegger I; Bektic J; Ladurner M; Jaschke W; Aigner F
    Urol Int; 2015; 94(3):313-8. PubMed ID: 25591786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies.
    Pokorny MR; de Rooij M; Duncan E; Schröder FH; Parkinson R; Barentsz JO; Thompson LC
    Eur Urol; 2014 Jul; 66(1):22-9. PubMed ID: 24666839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Added Value of Multiparametric Ultrasonography in Magnetic Resonance Imaging and Ultrasonography Fusion-guided Biopsy of the Prostate in Patients With Suspicion for Prostate Cancer.
    Maxeiner A; Stephan C; Durmus T; Slowinski T; Cash H; Fischer T
    Urology; 2015 Jul; 86(1):108-14. PubMed ID: 26142593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First round of targeted biopsies using magnetic resonance imaging/ultrasonography fusion compared with conventional transrectal ultrasonography-guided biopsies for the diagnosis of localised prostate cancer.
    Mozer P; Rouprêt M; Le Cossec C; Granger B; Comperat E; de Gorski A; Cussenot O; Renard-Penna R
    BJU Int; 2015 Jan; 115(1):50-7. PubMed ID: 24552477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In patients with a previous negative prostate biopsy and a suspicious lesion on magnetic resonance imaging, is a 12-core biopsy still necessary in addition to a targeted biopsy?
    Salami SS; Ben-Levi E; Yaskiv O; Ryniker L; Turkbey B; Kavoussi LR; Villani R; Rastinehad AR
    BJU Int; 2015 Apr; 115(4):562-70. PubMed ID: 25252133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The value of magnetic resonance imaging and ultrasonography (MRI/US)-fusion biopsy platforms in prostate cancer detection: a systematic review.
    Gayet M; van der Aa A; Beerlage HP; Schrier BP; Mulders PF; Wijkstra H
    BJU Int; 2016 Mar; 117(3):392-400. PubMed ID: 26237632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer: A Systematic Review.
    Haider MA; Yao X; Loblaw A; Finelli A
    Clin Oncol (R Coll Radiol); 2016 Sep; 28(9):550-67. PubMed ID: 27256655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial.
    Wysock JS; Rosenkrantz AB; Huang WC; Stifelman MD; Lepor H; Deng FM; Melamed J; Taneja SS
    Eur Urol; 2014 Aug; 66(2):343-51. PubMed ID: 24262102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TRUS-MRI image registration: a paradigm shift in the diagnosis of significant prostate cancer.
    Cornud F; Brolis L; Delongchamps NB; Portalez D; Malavaud B; Renard-Penna R; Mozer P
    Abdom Imaging; 2013 Dec; 38(6):1447-63. PubMed ID: 23860771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiparametric magnetic resonance imaging in the detection of prostate cancer.
    Durmus T; Baur A; Hamm B
    Rofo; 2014 Mar; 186(3):238-46. PubMed ID: 24452493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.